The Effect of Metformin on Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

International Journal of Endocrinology

Volumn 2016, Issue , 2016, Pages

  Liu, Wei ^a   Yang, Xiao Jie ^a  

^a GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; PLACEBO;

ADOLESCENT; ADOLESCENT OBESITY; ARTICLE; BODY MASS; BODY WEIGHT; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

EID: 84979663919     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2016/3854071     Document Type: Article

References (31)

1. D. Daneman, "Type 1 diabetes, " The Lancet, vol. 367, no. 9513, pp. 847-858, 2006.
2. American Diabetes Association, "11. Children and adolescents, " Diabetes Care, vol. 38, supplement 1, pp. S70-S76, 2015.
3. C. C. Barr, "Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, " The New England Journal of Medicine, vol. 342, no. 6, pp. 381-389, 2000.
4. F. Bacha and S. Klinepeter Bartz, "Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes, " Pediatric Diabetes, 2015.
5. S. A. Amiel, R. S. Sherwin, D. C. Simonson, A. A. Lauritano, and W. V. Tamborlane, "Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes, "The New England Journal of Medicine, vol. 315, no. 4, pp. 215-219, 1986.
6. S. Särnblad, M. Kroon, and J. Aman, "Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity, " European Journal of Endocrinology, vol. 149, no. 4, pp. 323-329, 2003.
7. B. J. Specht, R. P. Wadwa, J. K. Snell-Bergeon, K. J. Nadeau, F. K. Bishop, and D. M. Maahs, "Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes, " Journal of Pediatrics, vol. 162, no. 2, pp. 297-301, 2013.
8. The Diabetes Control and Complications Trial Research Group, "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus, " The New England Journal of Medicine, vol. 329, no. 14, pp. 977-986, 1993.
9. D. Russell-Jones and R. Khan, "Insulin-associated weight gain in diabetes-causes, effects and coping strategies, " Diabetes, Obesity and Metabolism, vol. 9, no. 6, pp. 799-812, 2007.
10. S. N. DuBose, J. M. Hermann, W. V. Tamborlane et al., "Obesity in youth with type 1 diabetes in Germany, Austria, and the United States, " Journal of Pediatrics, vol. 167, no. 3, pp. 627-632. e4, 2015.
11. Bristol-Myers Squibb, "Glucophage- Glucophage- XR, " 2016, http://www. Accessdata. fda. gov/drugsatfda docs/label/2008/ 020357s031, 021202s016lbl. pdf.
12. H. Schatz, G. Winkler, E. M. Jonatha, and E. F. Pfeiffer, "Studies on juvenile type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides, "Diabetes&Metabolism, vol. 1, no. 4, pp. 211-220, 1975.
13. B. U. Nwosu, L. Maranda, K. Cullen et al., "A randomized, double-blind, placebo-controlled trial of adjunctive metformin therapy in overweight/obese youth with type 1 diabetes, " PLoS ONE, vol. 10, no. 9, Article IDe0137525, 2015.
14. K. J. Nadeau, K. Chow, S. Alam et al., "Effects of low dose metformin in adolescents with type I diabetes mellitus: A randomized, double-blinded placebo-controlled study, " Pediatric Diabetes, vol. 16, no. 3, pp. 196-203, 2015.
15. I. M. Libman, K. M. Miller, L. A. DiMeglio et al., "Effect of metformin added to insulin on glycemic control among overweight/ obese adolescents with type 1 diabetes: A randomized clinical trial, " The Journal of the American Medical Association, vol. 314, no. 21, pp. 2241-2250, 2015.
16. S. Abdelghaffar and A. M. Attia, "Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents, " Cochrane Database of Systematic Reviews, no. 1, Article ID CD006691, 2009.
17. J. Hamilton, E. Cummings, V. Zdravkovic, D. Finegood, and D. Daneman, "Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: A randomized controlled trial, " Diabetes Care, vol. 26, no. 1, pp. 138-143, 2003.
18. K. F. Schulz, L. Chalmers, R. J. Hayes, andD. G. Altman, "Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials, "TheJournal of the AmericanMedical Association, vol. 273, no. 5, pp. 408-412, 1995.
19. A. R. Jadad, R. A. Moore, D. Carroll et al., "Assessing the quality of reports of randomized clinical trials: is blinding necessary" Controlled Clinical Trials, vol. 17, no. 1, pp. 1-12, 1996.
20. J. P. T. Higgins and S. Green, Eds., Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0, The Cochrane Collaboration, 2011, http://handbook. cochrane. org/.
21. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, "Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, " Annals of InternalMedicine, vol. 151, no. 4, pp. 264-269, 2009.
22. J. L. Chiang, M. S. Kirkman, L. M. B. Laffel, and A. L. Peters, "Type 1 diabetes through the life span: A position statement of the American Diabetes Association, " Diabetes Care, vol. 37, no. 7, pp. 2034-2054, 2014.
23. L. Ji, H. Li, X. Guo, Y. Li, R. Hu, and Z. Zhu, "Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial, " PLoS ONE, vol. 8, no. 2, Article ID e57222, 2013.
24. L. A. Donnelly, A. S. F. Doney, A. T. Hattersley, A. D. Morris, and E. R. Pearson, "The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes, " Diabetic Medicine, vol. 23, no. 2, pp. 128-133, 2006.
25. H. Ito, H. Ishida, Y. Takeuchi et al., "Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetesmellitus, " Nutrition and Metabolism, vol. 7, article 83, 2010.
26. C. Liu, D. Wu, X. Zheng, P. Li, and L. Li, "Efficacy and safety of metformin for patients with type 1 diabetes mellitus: A metaanalysis, " Diabetes Technology andTherapeutics, vol. 17, no. 2, pp. 142-148, 2015.
27. S. Vella, L. Buetow, P. Royle, S. Livingstone, H. M. Colhoun, and J. R. Petrie, "The use of metformin in type 1 diabetes: A systematic review of efficacy, " Diabetologia, vol. 53, no. 5, pp. 809-820, 2010.
28. B. Fruehwald-Schultes, K. M. Oltmanns, B. Toschek et al., "Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men, " Metabolism: Clinical and Experimental, vol. 51, no. 4, pp. 531-536, 2002.
29. EMERALD: effects of Metformin on cardiovascular function in adolescents with Type 1 diabetes, https://clinicaltrials. gov/ show/NCT01808690.
30. S. Lacigová, Z. Rusavý, Z. Jankovec, and P. Kyselová, "Metformin in the treatment of type 1 diabetics-a placebo controlled study, " Casops lékaru Ceských, vol. 140, no. 10, pp. 302-306, 2001.
31. S. Lacigová, Z. Rusavý, P. Kyselová, Z. Jankovec, R. Kárová, and D. Cechurová, "Short-term and long-term effect of metformin in type 1 diabetics, " Vnitrni Lekarstvi, vol. 47, no. 2, pp. 81-86, 2001.